Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | PLA2G4B | P0C869 | 6/20 | 0.46 |
| ▸ | RARB | P10826 | 7/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | RARA | P10276 | 1/20 | 0.43 |
| ▸ | MTOR | P42345 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2919381 | 0.89 | TP53 (0.51) | TP53TSHRPLA2G4BRARBMAPT | |
| SCHEMBL3032498 | 0.81 | CYP1A2 (0.47) | TP53TSHRALDH1A1 | |
| SCHEMBL18817713 | 0.80 | TP53 (0.54) | TP53TSHRPLA2G4BRARBMAPT | |
| SCHEMBL4938672 | 0.78 | TP53 (0.51) | TP53TSHRPLA2G4BRARBMAPT | |
| SCHEMBL27968723 | 0.78 | TP53 (0.51) | TP53TSHRPLA2G4BRARBMAPT | |
| SCHEMBL17982633 | 0.78 | TP53 (0.51) | TP53TSHRPLA2G4BRARBMAPT | |
| SCHEMBL4401536 | 0.76 | PLA2G4B (0.46) | TP53TSHRPLA2G4BKMT2APLA2G4A | |
| SCHEMBL690294 | 0.76 | TP53 (0.49) | TP53TSHRPLA2G4BRARBMAPT | |
| SCHEMBL6232656 | 0.75 | LMNA (0.49) | TSHRMAPTMEN1ALDH1A1KMT2A | |
| SCHEMBL6230648 | 0.75 | LMNA (0.49) | TSHRMAPTMEN1ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2157159-B1 | HYDRAULIC FLUID | IDEMITSU KOSAN CO (JP) | 2015-12-02 | — | — | EP | disclosed |
| EP-2674473-A2 | Hydraulic fluid and hydraulic system | IDEMITSU KOSAN CO., LTD. (JP) | 2013-12-18 | — | — | EP | disclosed |
| US-8299004-B2 | Hydraulic fluid and hydraulic system | IDEMITSU KOSAN CO., LTD. (JP) | 2012-10-30 | — | — | US | disclosed |
| US-20100130394-A1 | HYDRAULIC FLUID AND HYDRAULIC SYSTEM | IDEMITSU KOSAN CO., LTD (JP) | 2010-05-27 | — | — | US | disclosed |
| EP-2157159-A1 | HYDRAULIC FLUID AND HYDRAULIC SYSTEM | Idemitsu Kosan Co., Ltd. (JP) | 2010-02-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100130394-A1 | HYDRAULIC FLUID AND HYDRAULIC SYSTEM | AQP1, AQP3, TECR | TP53 1542/4885TSHR 4028/4885PLA2G4B 1788/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.